Liquidia (LQDA) Revenue & Revenue Breakdown
Liquidia Revenue Highlights
Latest Revenue (Y)
$14.00M
Latest Revenue (Q)
$4.45M
Main Segment (Y)
Promotion Agreement
Main Geography (Y)
Promotion Agreement
Liquidia Revenue by Period
Liquidia Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $14.00M | -19.97% |
| 2023-12-31 | $17.49M | 9.75% |
| 2022-12-31 | $15.94M | 23.98% |
| 2021-12-31 | $12.85M | 1637.81% |
| 2020-12-31 | $739.63K | -90.84% |
| 2019-12-31 | $8.07M | 198.20% |
| 2018-12-31 | $2.71M | -62.70% |
| 2017-12-31 | $7.26M | -45.08% |
| 2016-12-31 | $13.22M | - |
Liquidia generated $14.00M in revenue during NA 2024, up -19.97% compared to the previous quarter, and up 173.39% compared to the same period a year ago.
Liquidia Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-09-30 | $4.45M | 21.56% |
| 2024-06-30 | $3.66M | 23.12% |
| 2024-03-31 | $2.97M | -34.41% |
| 2023-12-31 | $4.53M | 23.19% |
| 2023-09-30 | $3.68M | -23.15% |
| 2023-06-30 | $4.79M | 6.52% |
| 2023-03-31 | $4.49M | -16.18% |
| 2022-12-31 | $5.36M | 69.35% |
| 2022-09-30 | $3.17M | -19.22% |
| 2022-06-30 | $3.92M | 12.20% |
| 2022-03-31 | $3.49M | 8.62% |
| 2021-12-31 | $3.22M | 1.14% |
| 2021-09-30 | $3.18M | -5.85% |
| 2021-06-30 | $3.38M | 9.48% |
| 2021-03-31 | $3.08M | 316.92% |
| 2020-12-31 | $739.63K | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | -100.00% |
| 2019-12-31 | $-120.00 | 100.00% |
| 2019-09-30 | - | -100.00% |
| 2019-06-30 | $8.07M | 100.00% |
| 2019-03-31 | - | -100.00% |
| 2018-12-31 | $568.40K | 234.89% |
| 2018-09-30 | $169.73K | -83.72% |
| 2018-06-30 | $1.04M | 12.63% |
| 2018-03-31 | $925.97K | -49.01% |
| 2017-12-31 | $1.82M | -0.26% |
| 2017-09-30 | $1.82M | -8.13% |
| 2017-06-30 | $1.98M | 20.91% |
| 2017-03-31 | $1.64M | - |
Liquidia generated $4.45M in revenue during Q3 2024, up 21.56% compared to the previous quarter, and up 92.94% compared to the same period a year ago.
Liquidia Revenue Breakdown
Liquidia Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 20 |
|---|---|
| Research and Development Services | - |
| Promotion Agreement | $739.63K |
Liquidia's latest annual revenue breakdown by segment (product or service), as of Dec 20: Promotion Agreement (100.00%).
Quarterly Revenue by Product
| Product/Service | Jun 19 | Dec 18 | Sep 18 | Jun 18 |
|---|---|---|---|---|
| Research And Development Services | $200.00 | $568.40K | $169.73K | $99.46K |
| Collaboration And Licensing Milestones | $1.35M | $45.06K | $45.06K | - |
| Collaboration And Licensing Non Refundable Upfront Payments | $6.73M | $1.17M | $943.42K | - |
Liquidia's latest quarterly revenue breakdown by segment (product or service), as of Jun 19: Collaboration And Licensing Non Refundable Upfront Payments (83.33%), Collaboration And Licensing Milestones (16.67%), and Research And Development Services (0.00%).
Liquidia Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 20 | Dec 19 | Dec 18 |
|---|---|---|---|
| Promotion Agreement | $739.63K | - | - |
| Research and Development Services | - | $200.00 | - |
| Non-Refundable Payments - Milestones | - | $1.35M | - |
| Non-Refundable Payments - Up-front Payments | - | $6.73M | - |
| Collaboration And Licensing Milestones | - | - | $45.06K |
| Collaboration And Licensing Non Refundable Upfront Payments | - | - | $1.17M |
| Research And Development Services | - | - | $1.49M |
Liquidia's latest annual revenue breakdown by geography, as of Dec 20: Promotion Agreement (100.00%).
Quarterly Revenue by Country
| Country | Jun 19 | Dec 18 | Sep 18 | Jun 18 |
|---|---|---|---|---|
| Research And Development Services | $200.00 | $568.40K | $169.73K | $99.46K |
| Collaboration And Licensing Milestones | $1.35M | $45.06K | $45.06K | - |
| Collaboration And Licensing Non Refundable Upfront Payments | $6.73M | $1.17M | $943.42K | - |
Liquidia's latest quarterly revenue breakdown by geography, as of Jun 19: Collaboration And Licensing Non Refundable Upfront Payments (83.33%), Collaboration And Licensing Milestones (16.67%), and Research And Development Services (0.00%).
Liquidia Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| UTHR | United Therapeutics | $2.88B | $748.90M |
| BMRN | BioMarin Pharmaceutical | $2.85B | $733.87B |
| TECH | Bio-Techne | $1.16B | $297.03M |
| MIRM | Mirum Pharmaceuticals | $336.89M | $77.88M |
| IMCR | Immunocore | $310.20M | $75.40M |
| LEGN | Legend Biotech | $285.14M | $93.99M |
| GOSS | Gossamer Bio | $114.70M | $9.48M |
| AGEN | Agenus | $103.46M | $25.11M |
| AMLX | Amylyx Pharmaceuticals | $87.37M | $416.00K |
| GERN | Geron | $76.50M | $28.21M |
| LQDA | Liquidia | $14.00M | $4.45M |
| KRON | Kronos Bio | $9.85M | $2.37M |
| XFOR | X4 Pharmaceuticals | $2.56M | $560.00K |
| LYRA | Lyra Therapeutics | $1.53M | $195.00K |
| PCVX | Vaxcyte | - | - |
| KALV | KalVista Pharmaceuticals | - | - |
| REPL | Replimune Group | - | - |
| ABOS | Acumen Pharmaceuticals | - | - |
| NVCT | Nuvectis Pharma | - | - |
| INZY | Inozyme Pharma | - | - |
| TERN | Terns Pharmaceuticals | - | - |
| NRXP | NRx Pharmaceuticals | - | - |
| LRMR | Larimar Therapeutics | - | - |